Ritonavir Terminated Phase 4 Trials for Acquired Immune Deficiency Syndrome (AIDS) / Human Immunodeficiency Virus (HIV) Infections Treatment

IndicationsStatusPurposePhase
TerminatedTreatment4
clinicaltrials.gov IdentifierTitleDrugs
NCT00981318Pilot Assessment of Lopinavir/Ritonavir and Maraviroc
NCT00775606Immune Reconstitution of Lopinavir/Ritonavir-Based vs Efavirenz-based HAART in Advanced HIV Disease
NCT00420355Pharmacokinetic Study of Two HIV Protease Inhibitors in Patients
NCT00386659Immune Reconstitution in naïve HIV Patients With CD4 <100 Cells/mL When Treated With Lopinavir or Efavirenz.
NCT00234962Study of Adherence Effects and Clinical Outcomes of Kaletra Based HIV Antiviral Therapy
NCT00661349Trial About Hepatic Security of Antiretroviral Treatment Based on Kaletra Versus Nevirapine in Co-infected HIV/HCV Patients
NCT00632970Raltegravir vs. Lopinavir/Ritonavir, Both in Combination With Truvada, in HIV+ Treatment Naive Individuals
NCT00531986HIV - Monotherapy in Switzerland (MOST-ch)
NCT00679926Kaletra and Viread in Antiretroviral Naïve Patients
NCT01118871The First Failure Study
NCT01068873Kaletra and Maraviroc in Antiretroviral Therapy (ART)-Naive Patients (KALMAR Study)
NCT00414284BOOST: Study of Increased Dosage of Lopinavir/Ritonavir (LPV/r)
NCT00765154NNRTI/PI Toxicity Switch to Darunavir Study